Patents by Inventor Lorraine Robb

Lorraine Robb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of modulating fertility in animals
    Publication number: 20070110712
    Abstract: The present invention relates generally to a method for controlling fertility and/or modulating the maintenance of pregnancy in animals. The present invention further provides an animal model useful for screening for therapeutic agents to treat infertility, to prevent or reduce spontaneous abortion and/or as contraceptive agents in animals.
    Type: Application
    Filed: January 16, 2007
    Publication date: May 17, 2007
    Inventors: Lorraine Robb, Harshal Nandurkar, Colin Begley
  • Novel regulatory molecule and genetic sequences encoding same
    Publication number: 20050118681
    Abstract: The present invention relates generally to a regulatory molecule and to genetic sequences encoding same. More particularly, the present invention provides a molecule involved in, associated with or which otherwise facilitates myogenesis. In a particularly preferred embodiment, the regulatory molecule is a transcription factor involved in the expression of genes resulting in the determination of skeletal muscle (a sequence encoding the regulatory molecule is disclosed within the specification as Seq. Id. No: 2). The identification of the regulatory molecule of the present invention permits the development of agents capable of modulating myogenesis including therapeutic agents capable of ameliorating aberrations in pyogenesis such as but not limited to myogenic cancers.
    Type: Application
    Filed: January 18, 2005
    Publication date: June 2, 2005
    Applicant: Walter and Eliza Hall Institute of Medical Research
    Inventors: Lorraine Robb, Glenn Begley, Richard Harvey
  • Isolated nucleic acid encoding murine musculin
    Patent number: 6884617
    Abstract: The present invention relates generally to a regulatory molecule and to genetic sequences encoding same. More particularly, the present invention provides a molecule involved in, associated with or which otherwise facilitates myogenesis. In a particularly preferred embodiment, the regulatory molecule is a transcription factor involved in the expression of genes resulting in the determination of skeletal muscle (a sequence encoding the regulatory molecule is disclosed within the specification as Seq. Id. No: 2). The identification of the regulatory molecule of the present invention permits the development of agents capable of modulating myogenesis including therapeutic agents capable of ameliorating aberrations in pyogenesis such as but not limited to myogenic cancers.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: April 26, 2005
    Assignee: Walter and Eliza Hall Institute of Medical Research
    Inventors: Lorraine Robb, Glenn C. Begley, Richard P. Harvey